Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
167 hedge funds and large institutions have $708M invested in Spectrum Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 73 increasing their positions, 37 reducing their positions, and 19 closing their positions.
97% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 37
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
1% more funds holding
Funds holding: 165 → 167 (+2)
3% less capital invested
Capital invested by funds: $733M → $708M (-$25.3M)
73% less call options, than puts
Call options by funds: $3.81M | Put options by funds: $14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$6.94M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.6M |
| 3 |
BlackRock
New York
|
+$5.4M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.54M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$6.43M |
| 2 |
State Street
Boston,
Massachusetts
|
-$6.2M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.74M |
| 4 |
Morgan Stanley
New York
|
-$3.36M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$2.73M |
SPPI Hedge Fund Activity: Q3 2019 in Review
167 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2019, worth a combined $708M — down 3.4% from $733M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new SPPI positions and 19 closed out — a net gain of 2 holders — while 73 added to existing stakes and 37 trimmed.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $6.94M. The largest seller was Citadel Advisors, cutting an estimated $6.43M.
- 167 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2019, up from 165 in Q2 2019.
- Funds reported $708M of Spectrum Pharmaceuticals Inc stock for Q3 2019, down 3.4% quarter-over-quarter.
- 21 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2019 and 19 closed out, a net change of +2 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q3 2019 was ArrowMark Colorado Holdings, an estimated $6.94M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2019 was Citadel Advisors, an estimated $6.43M sold.
Based on aggregated 13F filings for Q3 2019.